Review





Similar Products

human serum ca19 9 level  (Tosoh Corporation)
86
Tosoh Corporation human serum ca19 9 level
Human Serum Ca19 9 Level, supplied by Tosoh Corporation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ca19-9+level/9+ca19/us12448654-410-0-11
Average 86 stars, based on 1 article reviews
human serum ca19 9 level - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
analysis of serum tfpi2, ca125, ca19-9, and cea levels  (Tosoh Corporation)
90
Tosoh Corporation analysis of serum tfpi2, ca125, ca19-9, and cea levels
Baseline characteristics of 328 patients with endometrial cancer in the TFPI2-positive and TFPI2-negative groups
Analysis Of Serum Tfpi2, Ca125, Ca19 9, And Cea Levels, supplied by Tosoh Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ca19-9+level/tfpi2+elisa+kit/pmc11351603-278-20-29
Average 90 stars, based on 1 article reviews
analysis of serum tfpi2, ca125, ca19-9, and cea levels - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
ca19-9 level  (Tosoh Corporation)
90
Tosoh Corporation ca19-9 level
Baseline characteristics of 328 patients with endometrial cancer in the TFPI2-positive and TFPI2-negative groups
Ca19 9 Level, supplied by Tosoh Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ca19-9+level/ca19+9/us12037647-412-0-11
Average 90 stars, based on 1 article reviews
ca19-9 level - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
ca19-9 levels  (Johns Hopkins HealthCare)
90
Johns Hopkins HealthCare ca19-9 levels
Baseline characteristics of 328 patients with endometrial cancer in the TFPI2-positive and TFPI2-negative groups
Ca19 9 Levels, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ca19-9+level/ca19+9+tumor+marker+gene+test/pmc11191066-83-18-24
Average 90 stars, based on 1 article reviews
ca19-9 levels - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
ca19-9 level  (Wolters Kluwer Health)
90
Wolters Kluwer Health ca19-9 level
Baseline characteristics of 328 patients with endometrial cancer in the TFPI2-positive and TFPI2-negative groups
Ca19 9 Level, supplied by Wolters Kluwer Health, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ca19-9+level/ca19+9/10__1097_slash_sla__0000000000006209-114-10-25
Average 90 stars, based on 1 article reviews
ca19-9 level - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
ca19 9 concentration serum levels  (Thermo Fisher)
86
Thermo Fisher ca19 9 concentration serum levels
Baseline characteristics of 328 patients with endometrial cancer in the TFPI2-positive and TFPI2-negative groups
Ca19 9 Concentration Serum Levels, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ca19-9+level/pmc08243252__HEP___73___144___s001-81-0-9
Average 86 stars, based on 1 article reviews
ca19 9 concentration serum levels - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
serum ca19-9 levels  (SATAKE)
90
SATAKE serum ca19-9 levels
Baseline characteristics of 328 patients with endometrial cancer in the TFPI2-positive and TFPI2-negative groups
Serum Ca19 9 Levels, supplied by SATAKE, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ca19-9+level/carbohydrate+antigen+19+9/pmc07409286-97-4-0
Average 90 stars, based on 1 article reviews
serum ca19-9 levels - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
scc, ca125, ca19-9 levels  (Takeda)
90
Takeda scc, ca125, ca19-9 levels
Baseline characteristics of 328 patients with endometrial cancer in the TFPI2-positive and TFPI2-negative groups
Scc, Ca125, Ca19 9 Levels, supplied by Takeda, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ca19-9+level/serum+ca125+levels/pm30052166-237-13-0
Average 90 stars, based on 1 article reviews
scc, ca125, ca19-9 levels - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
ca19 9 levels  (Cusabio)
85
Cusabio ca19 9 levels
Baseline characteristics of 328 patients with endometrial cancer in the TFPI2-positive and TFPI2-negative groups
Ca19 9 Levels, supplied by Cusabio, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ca19-9+level/Human+carbonhydrate+antigen+19-9+(CA19-9)+ELISA+kit/pm27223429-111-30-42
Average 85 stars, based on 1 article reviews
ca19 9 levels - by Bioz Stars, 2026-10
85/100 stars
  Buy from Supplier
ca19 9 levels  (Monobind)
94
Monobind ca19 9 levels
Baseline characteristics of 328 patients with endometrial cancer in the TFPI2-positive and TFPI2-negative groups
Ca19 9 Levels, supplied by Monobind, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ca19-9+level/Recovered+Plasma+-+Defibrinated/pm28232049-111-9-27
Average 94 stars, based on 1 article reviews
ca19 9 levels - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

Image Search Results


Baseline characteristics of 328 patients with endometrial cancer in the TFPI2-positive and TFPI2-negative groups

Journal: BMC Cancer

Article Title: Tissue factor pathway inhibitor 2 as a serum biomarker for endometrial cancer: a single-center retrospective study

doi: 10.1186/s12885-024-12827-0

Figure Lengend Snippet: Baseline characteristics of 328 patients with endometrial cancer in the TFPI2-positive and TFPI2-negative groups

Article Snippet: The other authors declare no conflicts of interest directly relevant to the content of this article.The analysis of serum TFPI2, CA125, CA19-9, and CEA levels was outsourced to the Tosoh Corporation by the Kanagawa Cancer Center.

Techniques:

Pearson’s correlation analysis between serum TFPI2 and CA125 levels. There was a low correlation between serum TFPI2 and CA125 levels ( r = 0.203, p < 0.001). CA, cancer antigen; TFPI2, tissue factor pathway inhibitor 2

Journal: BMC Cancer

Article Title: Tissue factor pathway inhibitor 2 as a serum biomarker for endometrial cancer: a single-center retrospective study

doi: 10.1186/s12885-024-12827-0

Figure Lengend Snippet: Pearson’s correlation analysis between serum TFPI2 and CA125 levels. There was a low correlation between serum TFPI2 and CA125 levels ( r = 0.203, p < 0.001). CA, cancer antigen; TFPI2, tissue factor pathway inhibitor 2

Article Snippet: The other authors declare no conflicts of interest directly relevant to the content of this article.The analysis of serum TFPI2, CA125, CA19-9, and CEA levels was outsourced to the Tosoh Corporation by the Kanagawa Cancer Center.

Techniques:

Multivariate analysis of prognostic factors for overall survival

Journal: BMC Cancer

Article Title: Tissue factor pathway inhibitor 2 as a serum biomarker for endometrial cancer: a single-center retrospective study

doi: 10.1186/s12885-024-12827-0

Figure Lengend Snippet: Multivariate analysis of prognostic factors for overall survival

Article Snippet: The other authors declare no conflicts of interest directly relevant to the content of this article.The analysis of serum TFPI2, CA125, CA19-9, and CEA levels was outsourced to the Tosoh Corporation by the Kanagawa Cancer Center.

Techniques: